Phase II study of neoadjuvant bevacizumab and radiotherapy for resectable soft tissue sarcomas.
International journal of radiation oncology, biology, physics.
Times cited: 37
BIM expression in treatment-naive cancers predicts responsiveness to kinase inhibitors.
Times cited: 142
- Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08). Neuro-Oncology. 2009 Academic Article GET IT
- Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: involvement of transforming growth factor beta1.
Times cited: 106
- Enhancement of fluid filtration across tumor vessels: Implication for delivery of macromolecules. Proceedings of the National Academy of Sciences of the United States of America. 1999 Conference Paper GET IT